XML 21 R7.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Total
Common Stock: Class A Common Stock, Class B Common Stock and Class C Capital Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Beginning Balance at Dec. 31, 2013 $ 567,796 $ 12 $ 651,905 $ (84,121)  
Beginning Balance (in shares) at Dec. 31, 2013   118,208,898      
Issuance of common and capital stock upon exercise of stock options 23,923   23,923    
Issuance of common and capital stock upon exercise of stock options (in shares)   3,970,527      
Issuance of common and capital stock related to vesting of restricted stock units   208,095      
Share-based compensation expense 40,670   40,670    
Net loss (43,610)     (43,610)  
Ending Balance at Dec. 31, 2014 588,779 $ 12 716,498 (127,731)  
Ending Balance (in shares) at Dec. 31, 2014   122,387,520      
Issuance of common and capital stock in connection with an acquisition 1,883,728 $ 5 1,883,723    
Issuance of common and capital stock in connection with an acquisition (in shares)   51,779,112      
Equity award vesting acceleration in connection with restructuring 14,859   14,859    
Fair value of equity awards assumed in connection with an acquisition 82,840   82,840    
Debt premium recorded in additional paid-in capital in connection with an acquisition 126,386   126,386    
Issuance of common and capital stock upon exercise of stock options 24,423 $ 1 24,422    
Issuance of common and capital stock upon exercise of stock options (in shares)   2,732,767      
Issuance of common and capital stock related to vesting of restricted stock units   1,899,531      
Shares and value of restricted stock units withheld for tax liability (8,150)   (8,150)    
Shares and value of restricted stock units withheld for tax liability (in shares)   (324,013)      
Share-based compensation expense 115,533   115,533    
Net loss (148,874)     (148,874)  
Other comprehensive income (loss) (471)       $ (471)
Ending Balance at Dec. 31, 2015 2,679,053 $ 18 2,956,111 (276,605) (471)
Ending Balance (in shares) at Dec. 31, 2015   178,474,917      
Issuance of common and capital stock upon exercise of stock options 31,211   31,211    
Issuance of common and capital stock upon exercise of stock options (in shares)   2,518,172      
Issuance of common and capital stock related to vesting of restricted stock units   1,487,263      
Shares and value of restricted stock units withheld for tax liability (616)   (616)    
Shares and value of restricted stock units withheld for tax liability (in shares)   (21,634)      
Share-based compensation expense 116,979   116,979    
Portion of repurchase price recorded in additional paid-in capital in connection with partial repurchase of 2020 Notes (127,615)   (127,615)    
Equity component of issuance of 2021 Notes, net of issuance costs of $2,494 91,400   91,400    
Premiums paid for Capped Call Confirmations (36,616)   (36,616)    
Net loss (220,438)     (220,438)  
Other comprehensive income (loss) 229       229
Ending Balance at Dec. 31, 2016 $ 2,533,587 $ 18 $ 3,030,854 $ (497,043) $ (242)
Ending Balance (in shares) at Dec. 31, 2016   182,458,718